Establishment Labs Holdings Inc. (ESTA)

Market Cap	1.17B
Revenue (ttm)	153.07M
Net Income (ttm)	-70.61M
Shares Out	28.00M
EPS (ttm)	-2.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	751,609
Open	37.34
Previous Close	37.52
Day's Range	37.11 - 41.99
52-Week Range	22.05 - 60.12
Beta	1.21
Analysts	Buy
Price Target	60.50 (+44.7%)
Earnings Date	Nov 7, 2024

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 908
• Stock Exchange: NASDAQ
• Ticker Symbol: ESTA
• Website: https://www.establishmentlabs.com

Financial Performance

In 2023, ESTA's revenue was $165.15 million, an increase of 2.13% compared to the previous year's $161.70 million. Losses were -$78.50 million, 4.38% more than in 2022.

Analyst Forecast

According to 6 analysts, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $60.5, which is an increase of 44.70% from the latest price.

Price Target

$60.5

(44.70% upside)

Analyst Consensus: Buy